Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharco Pharmaceuticals is one of Egypt’s largest pharmaceutical manufacturers with a dominant market share. It produces over 450–500 generic and branded generic drugs across a wide range of therapeutic areas. The company played a major role in hepatitis C treatment access in Egypt with its sofosbuvir-based therapy Gratisovir. Its pipeline includes both established commercial products and new generics or branded generics under development. The company exports to more than fifty countries and operates multiple manufacturing facilities certified to international standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharco Pharmaceuticals.